Sign in
BioinformaticsBMC Bioinformatics
Peer-reviewed journal article

DR2S: An Integrated Algorithm Providing Reference-Grade Haplotype Sequences from Heterozygous Samples

Steffen KlasbergiD, Alexander H. SchmidtiD, Vinzenz LangeiD, Gerhard SchöfliD

Abstract

BackgroundHigh resolution HLA genotyping of donors and recipients is a crucially important prerequisite for haematopoetic stem-cell transplantation and relies heavily on the quality and completeness of immunogenetic reference sequence databases of allelic variation. ResultsHere, we report on DR2S, an R package that leverages the strengths of two sequencing technologies - the accuracy of next-generation sequencing with the read length of third-generation sequencing technologies like PacBios SMRT sequencing or ONTs nanopore sequencing - to reconstruct fully-phased high-quality full-length haplotype sequences. Although optimised for HLA and KIR genes, DR2S is applicable to all loci with known reference sequences provided that full-length sequencing data is available for analysis. In addition, DR2S integrates supporting tools for easy visualisation and quality control of the reconstructed haplotype to ensure suitability for submission to public allele databases. ConclusionsDR2S is a largely automated workflow designed to create high-quality fully-phased reference allele sequences for highly polymorphic gene regions such as HLA or KIR. It has been used by biologists to successfully characterise and submit more than 500 HLA alleles and more than 500 KIR alleles to the IPD-IMGT/HLA and IPD-KIR databases.

02 /Specification & Classification

Click any tag to browse matching papers

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISLarjo '17Chen '20Lee '18Dilthey '15Maiers '19Orenbuch '19
62% semantic matchImmunology
A. Larjo, R. Eveleigh, E. Kilpelainen+4 more·bioRxiv·Sep 1, 2017